Our mRNA-seq results showed that Dvl2 overexpression in RA-FLSs suppressed the NF-κB pathway by decreasing the nuclear translocation of P65 and interacting with it to inhibit its binding to the promoters of NF-κB target genes (anti-apoptotic and inflammatory genes). This evidence concerns the gene DVL2 and rheumatoid arthritis.